All posts by imreal

Lavi Industries Announces New Products for Safe Social Distancing While Queuing


Qtrac Smartphone Queuing

“Businesses are faced with an immediate need to implement new, safer queuing strategies. The lead time from decision to installation needs to be quick, allowing businesses the opportunity to get back to serving their customers and keeping them safe” – Perry Kuklin, Director of Marketing

The month of March saw a dramatic shift in the way businesses serve their customers. Concerns over Coronavirus (COVID-19), has led to an increased focus on customer safety and health, creating new queuing challenges for restaurants, grocery stores, retailers, laboratories, pharmacies, medical centers and others. How businesses and customers physically interact with each other has rarely been more important than it is in this time of abrupt change.

Lavi Industries is familiar with adapting to new and sudden changes in queuing, with over 40 years of assisting the TSA and countless other agencies and organizations with queuing strategies, products and services. “Businesses are faced with an immediate need to implement new, safer queuing strategies. The lead time from decision to installation needs to be quick, allowing businesses the opportunity to get back to serving their customers and keeping them safe” says Perry Kuklin, Director of Marketing for Lavi Industries. “We want to help, and one way we can do that is to look at the products and services we offer and find a way to make them even more accessible and useful”.

One such service is Lavi’s new smartphone queuing technology. “We have been offering virtual queuing through our Qtrac VR product for several years now, and we know the benefits it provides our customers,” states Kuklin. “It enables contactless engagement, allows the customer to wait outside the business premisis or in the safety of their car, and provides the business a way to control customer access into the building or space.”The lead time for implementaton of our standard Qtrac VR would average 2-3 weeks due to all of the customization options. However, we knew our customers needed something sooner than that”, Kuklin explains, “so we asked our team to create a simpler solution that could be implemented immediately”. The result was Qtrac VR Smartphone Queuing. With no app or hardware to install, businesses are able to begin using the program within days. “We’ve recently implemented this program into 300 branches at a financial institution in just 5 days. Smaller implementations take just a day,” states Kuklin. Customers simply scan a QR code using their smartphone camera or text their name. They are then automatically directed to a webpage where they can track their place in line, ask for more time, or communicate with staff if necessary. The webpage, or a text message, then alerts the customer when it is their turn for service.

“It’s the safest solution for providing social distancing to your customers, with the added benefit of being quick and easy to use and implement,” says Kuklin. “However, we know there are some businesses that may still require a physical queue, and we wanted to make sure we helped them as well”. Seeing the lines of customers outside grocery stores was enough inspiration to realize what needed to happen. “People are not used to social distancing yet, and don’t always recognize six feet of safe distance without visual cues,” says Kuklin. “Our portable retractable belt stanchions not only help organize queues and help keep waiting customers safe, but they also happen to have 7’ long retractable belts – perfect for identifying safe social distance.” Lavi Industries has designed and begun selling stanchions with a new custom belt, printed with visual cues to help customers maintain a minimum six feet of safe space between them. In addition, stanchion signs have been designed to help reinforce safe social distance practices. The signage and custom belts are easily installed on any of the retractable belt stanchions offered by Lavi Industries, and take only a few minutes to install and set-up.

About Lavi Industries

Based in Valencia, California, Lavi Industries is the premier provider of public guidance and crowd control solutions in the Americas. Leveraging its portfolio of world-class brands – Beltrac® stanchions, Directrac® signage systems, Qtrac® electronic queuing systems, and NeXtrac® in-queue merchandising systems – Lavi has helped the world’s leading companies effectively guide people in, through, and out of their facilities. More information is available at https://www.lavi.com/.

Share article on social media or email:

RED Company Taps Life Sciences and Healthcare Industry Relationships to Deliver Supplies to Those in Need


News Image

Carmela Roth

It is my passion to deliver a high-touch approach, creative cost savings, flexibility and tenacity to each customer. This is more important than ever, especially given our service-centric company culture in this very difficult time.

Today RED Company founder and President, Carmela Roth, announced the launch of her sourcing website to support businesses looking to quickly source healthcare supplies. Due to her long-standing relationships within the life sciences and healthcare industry, RED Company has been sourcing goods internationally and making them available to U.S. businesses in a seamless manner for years through its division known as RED Swag.    

“We’ve been supplying hand sanitizer, wet wipes, first aid kits and disaster prepaRED kits to companies for years. We have international and domestic suppliers ready to tap into. It is my passion to deliver a high-touch approach, creative cost savings, flexibility and tenacity to each customer. This is more important than ever, especially given our service-centric company culture in this very difficult time,” said Roth.

In addition to the WFH kits, WOFH (work out from home) kits, stay well kits and traditional healthcare items Roth has been selling via RED Swag, the new site will also carry:


  • Masks and Face Shields
  • Hand Sanitizer
  • Shoe Covers
  • Isolation Gowns

The website, COVID-19HealthGear.com, will serve to support those public and private sector entities looking to source health gear more efficiently.

About Carmela Roth

As RED Company’s founder and President, Carmela Roth brings over 30 years of experience and dedication in meeting planning, special event production, sourcing and logistics.

In 2017, Roth was named to the Board of Directors for Diversity Alliance for Science, a platform to identify, attract and develop small and/or diverse businesses to drive inclusive procurement practices in corporate, academic and governmental entities within the life science and healthcare industries. RED Company has been recognized as one of the LA Business Journal’s Top 100 Women-Owned Businesses for the last seven years and their Top 100 Fastest Growing Companies for three. In 2016, RED Company earned recognition in Inc. 500’s 5000 Fastest Growing Private Companies in the US.

RED Company’s service-centric culture and desire to give back is marked through its Power-full Acts of Compassion and Kindness™ initiatives through their recently launched RED PACK™ Program.

To interview or collaborate with Roth, please email carmela.roth@redcompany.com or covid19@redcompany.com.

Share article on social media or email:

Experienced Business Owner and Leader in Marketing Brings The Growth Coach to Scottsdale Region


Paul Conant

I am looking forward to working with business owners and company leaders to learn about their business, help them define their goals, assist them with the creation of a strategic plan to reach those goals, and then keep them accountable for progress along the way. – Paul Conant

Paul Conant has been advising business owners and company leaders since he started working with technology in the 1980s, but as he worked his way into business management positions and then built his own marketing company. He found that many business owners had the same challenge: they wanted to focus on marketing, sales and growth when really the business needed organization, structure and systems support first.

Although Conant was always willing to help coach business owners on ways to make improvements, he’s looking forward to being able to offer that support full time as the owner of his new business – The Growth Coach of Scottsdale.

The Growth Coach is the largest provider of affordable group coaching workshops in the nation, but coaches also offer group and one-on-one coaching for sales professionals, managers, management teams, self-employed professionals and more through a wide variety of programs via three industry-leading series – their Foundational Series, Fundamental Series and Fast Forward Series. The Growth Coach’s mission is to help business leaders build more successful businesses and more balanced lives. Conant will be serving clients in Phoenix, Scottsdale, Fountain Hills, Chandler, Tempe and the surrounding areas in Arizona.

“As I was working with businesses on marketing tactics – especially with helping them to be found online – I realized businesses had deeper issues. For example, if you have a website with a phone number, but you don’t have an answering service or anyone to take those calls 24/7, then you are missing a huge number of potential leads. There have to be processes in place to handle whatever kinds of marketing, sales or growth strategies you’re implementing and, in many cases, there are fundamental structure issues that just need to be worked through. As a Growth Coach, I’m better equipped to help business owners and company leaders navigate and overcome those challenges,” Conant said.

Conant started his career in the 1980s when he launched his own electronics repair company and started helping people with digital marketing. He now owns Gizoom Marketing and Smile Esthetics Scottsdale Dental Office and has a background in retail management.

As a Growth Coach, Conant is certified in The Strategic Mindset coaching process, which adheres to the standards, practices and policies that the International Coaching Federation has set forth in their Code of Professional Standards and Ethics. The company’s landmark Strategic Mindset Process is so effective that it comes with a money-back guarantee.

“So many business owners, especially small business owners, are out there playing whack-a-mole. They are working 80 hours a week and they are exhausted from constantly putting out fires – but they aren’t growing their business or finding any great success. They are surviving rather than thriving,” Conant said. “As a Growth Coach, I am looking forward to working with business owners and company leaders to learn about their business, help them define their goals, assist them with the creation of a strategic plan to reach those goals, and then keep them accountable for progress along the way. I’m excited to help people slow down, step back and do more than survive.”

The Growth Coach, founded in Cincinnati, Ohio, sold its first franchise in 2003, but its leaders have a successful 20-year track record of helping business leaders find success and balance. Today the business and sales coaching franchise is in more than 100 markets worldwide. The Growth Coach was included in Bond’s “Top 100 Franchises” and recognized in Entrepreneur Magazine’s “Franchise 500” and “Best of the Best,” in USA Today and has been featured on FOX, CBS and NBC.

For more information about how The Growth Coach of Scottsdale can help you and your business, call (480) 750-7613, email PConant@TheGrowthCoach.com or visit http://www.TheGrowthCoachScottsdale.com.

Share article on social media or email:

RSNA Publishes Fleischner Society Statement on Chest Imaging and COVID-19


A multinational consensus statement from the Fleischner Society on the role of chest imaging in the management of patients with COVID-19 was jointly published today in the journals Radiology and Chest.

“We need to understand that conditions across the globe vary greatly. Our goal in developing this statement was to offer guidance that is sensitive to these differences and applicable broadly,” said Geoffrey D. Rubin, M.D., George B. Geller Professor of Cardiovascular Research, professor of radiology and bioengineering at Duke University School of Medicine in Durham, North Carolina.

The statement represents the collective opinions and perspectives of thoracic radiology, pulmonology, intensive care, emergency medicine, laboratory medicine and infection control experts practicing in 10 countries, representative of the highest burden of COVID-19 worldwide.

“The willingness of experts from around the world to pause from their care of patients to contribute their knowledge and experience toward this international consensus was inspiring,” Dr. Rubin said.

Chest CT and X-ray are key tools in the diagnosis and management of numerous respiratory ailments, but their role in the management of COVID-19 has not been considered within the context of many variables, including the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints.

“The Fleischner statement was uniquely comprised of a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments,” said Radiology Editor David A. Bluemke, M.D.

The panel evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions and resource constraints.

Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of chest X-ray and CT in the management of COVID-19.

The results suggested that imaging is not routinely indicated in asymptomatic individuals or patients with suspected COVID-19 and mild clinical symptoms. Use of chest imaging is indicated in patients with COVID-19 who have worsening respiratory status. Imaging is also indicated for patients with moderate to severe features of COVID-19 regardless of COVID-19 test results.

In a resource-constrained environment (lack of personal protection equipment or availability of COVID-19 testing), imaging is indicated for medical triage of patients with suspected COVID-19 who present with moderate to severe clinical features and a high pre-test probability of disease.

The panel also found that CT is appropriate in patients with functional impairment and/or hypoxemia (low level of oxygen in the blood) after recovery from COVID-19. When there is known community transmission, evidence of COVID-19 has been incidentally found on CT scans. In these cases, patients should have COVID-19 testing using a reverse-transcription polymerase chain reaction (RT-PCR) viral assay.

The authors note that this consensus statement represents opinion at a moment in time within a highly dynamic environment where the status of regional epidemics and the availability of critical resources to combat those epidemics vary daily. Recommendations may undergo refinement as the situation evolves.

“Currently, no therapy has been confirmed to alter the course of COVID-19, there is no known cure, and there is no vaccine for prevention,” Dr. Rubin said. “As effective treatments are developed, thoracic imaging may find new roles by establishing treatment response or characterizing patients as likely responders to novel therapies.”

RSNA is committed to connecting radiologists and the radiology community to the most timely and useful COVID-19 information and resources. RSNA’s COVID-19 Resources page houses the latest guidance, original research, image collection and more. The page will be updated on an ongoing basis.

An associated special edition podcast from Dr. Bluemke is available.

“The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.” Geoffrey D. Rubin, Christopher J. Ryerson, Linda B. Haramati, Nicola Sverzellati, Jeffrey P. Kanne, Suhail Raoof, Neil W. Schluger, Annalisa Volpi, Jae-Joon Yim, Ian B. K. Martin, Deverick J. Anderson, Christina Kong, Talissa Altes, Andrew Bush, Sujal R. Desai, Jonathan Goldin, Jin Mo Goo, Marc Humbert, Yoshikazu Inoue, Hans-Ulrich Kauczor, Fengming Luo, Peter J. Mazzone, Mathias Prokop, Martine Remy-Jardin, Luca Richeldi, Cornelia M. Schaefer-Prokop, Noriyuki Tomiyama, Athol U. Wells and Ann N. Leung.

Radiology is edited by David A. Bluemke, M.D., Ph.D., University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/radiology)

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)

The Fleischner Society is an international, multidisciplinary medical society for thoracic radiology, dedicated to the diagnosis and treatment of diseases of the chest. (Fleischner.memberclicks.net)

For patient-friendly information on chest imaging, visit RadiologyInfo.org.

Ziegler Advises Physician Housecalls On Its Investment By Council Capital


Chris Hendrickson, Managing Director in Ziegler’s Healthcare Corporate Finance practice stated, “Hank and Cindy have demonstrated the ability to rapidly expand into new markets while adding providers and integrating practices operationally…”

Ziegler, a specialty investment bank, is pleased to announce its role in advising Physician Housecalls (PHC) on its investment by Council Capital (Council). PHC is the leading provider of home-based primary care in Oklahoma and Kansas, and is rapidly expanding its current footprint in surrounding states. PHC will use this investment to fund its expansion as well as gain access to Council’s sophisticated CEO Council Model, which has demonstrated considerable success driving growth for emerging growth healthcare companies.

Founded in 2012, PHC provides convenient access to the care needs of homebound patients focusing primarily on those within the Medicare population with two or more chronic diseases that have difficulty leaving their home. PHC deploys physicians, nurse practitioners and physician assistants with primary care experience to the home and via telehealth. PHC has recently expanded into Kansas through acquisition and has numerous expansion targets under LOI. Key themes within healthcare such as the drive to see patients within the lowest cost setting, the push to fee for value as well as specific programs such as Primary Care First – a five year Medicare demonstration that is driving significantly increased reimbursement across 26 regions, are key drivers that will enable PHC’s sustained growth.

PHC is led by CEO, Hank Ross, and VP Clinical Services, Cindy Longanacre, who were successful home health operators before starting PHC to address a critical need for homebound patients. Hank Ross stated, “Significant forces within healthcare are enabling the emergence of home based primary care.” Ross continued, “We want to expand our key learnings into new markets and Council Capital has unique executive-level resources that will help us expand our footprint and capabilities.”

Chris Hendrickson, Managing Director in Ziegler’s Healthcare Corporate Finance practice stated, “Hank and Cindy have demonstrated the ability to rapidly expand into new markets while adding providers and integrating practices operationally. Growth capital combined with Council Capital’s demonstrated expertise at growing companies will be critical in PHC’s next stage, as it looks to become a larger regional player and ultimately a national leader within home based primary care.”

Eric Keen, General Partner at Council Capital, commented, “Home based primary care is an investment theme we have been investigating for more than a year. PHC offers an innovative and effective service that greatly improves the patient’s quality of care and satisfaction, reduces costs to the healthcare system, and creates a more meaningful practice experience for providers. These attributes align strongly with our strategy of investing on the “right side of change in healthcare” – where we are able to grow and generate returns by investing into companies that improve the patient experience while also reducing cost.” Keen continued, “We are excited to be partnering with the management team at Physician Housecalls and look forward to supporting them in their current mission while also working to further develop and enhance the organization to drive further growth.”

Ziegler’s Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.

For more information about Ziegler, please visit us at http://www.ziegler.com.

About Ziegler:

Ziegler is a privately held, national boutique investment bank, capital markets and proprietary

investments firm. It has a unique focus on healthcare, senior living and education sectors, as

well as general municipal and structured finance. Headquartered in Chicago with regional and

branch offices throughout the U.S., Ziegler provides its clients with capital raising, strategic advisory

services, fixed income sales, underwriting and trading as well as Ziegler Credit, Surveillance and Analytics. To learn more, visit http://www.ziegler.com.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

Share article on social media or email:

PTW Announces First North American Installation and FDA 510(k) Clearance of BEAMSCAN® MR Motorized 3D Water Phantom


PTW_BEAMSCAN_MR_for_Elekta_Unity

PTW BEAMSCAN® MR for Elekta Unity at Princess Margaret Cancer Centre

The BEAMSCAN MR enables us to conduct in-depth radiation beam characterization and quality assurance of our Unity MR-LINAC. Because it is designed for compatibility with the Elekta Unity, we can perform accurate beam profile and depth-dose curve measurements in the specific geometry of the MR-LINAC.

PTW has installed the first BEAMSCAN® MR motorized 3D water phantom in North America at the Princess Margaret Cancer Centre in Toronto, Ontario, Canada. In addition, PTW announces that the BEAMSCAN MR water phantom recently received 510(k) clearance from the U.S. Food and Drug Administration and is now available for sale within the United States. The BEAMSCAN MR motorized 3D water phantom provides a dedicated, fully equipped solution for beam data commissioning and annual QA of MR-LINACs.

The Princess Margaret Cancer Centre is part of the University Health Network, which is affiliated with the University of Toronto. It is one of the largest comprehensive cancer treatment facilities in the world and the largest radiation treatment facility in Canada. It houses two state-of-the-art MR-LINAC systems: an Elekta Unity system as well as an MR-on-rail system combined with a linear accelerator and a brachytherapy afterloader (MRgRT system).

“We invested in the BEAMSCAN MR because it is an essential tool for the commissioning and maintenance of our Elekta Unity MR-LINAC,” said Daniel Létourneau PhD, head of physics in the Radiation Medicine Program at Princess Margaret Cancer Centre. Dr. Létourneau leads clinical operations as well as the academic and education activities of the Medical Physics Department at the Princess Margaret Cancer Centre.

“The BEAMSCAN MR enables us to conduct in-depth radiation beam characterization and quality assurance of our Unity MR-LINAC,” Dr. Létourneau added. “Because it is designed for compatibility with the Elekta Unity, we can perform accurate beam profile and depth-dose curve measurements in the specific geometry of the MR-LINAC.”

The BEAMSCAN MR water phantom is available for both the Elekta Unity and ViewRay® MRIdian® MR-LINACs. It is the first motorized 3D water phantom suitable for clinical use in a 1.5 T MR environment. The BEAMSCAN MR phantom comes ready to use on a single carriage and includes everything needed for operation.

PTW is continuously developing innovative dosimetry solutions to deliver fast, precise measurements for complex radiation equipment and treatment plans. PTW delivers a full line of dosimetry solutions for acceptance testing, beam data commissioning, and machine- and patient-specific QA.

For more information about the BEAMSCAN MR motorized 3D water phantom, visit the MR-guided radiotherapy QA solutions product page on PTW’s website: https://www.ptwdosimetry.com/en/application-pages/mr-guided-radiotherapy/.

Find details about The Princess Margaret Cancer Centre here https://www.uhn.ca/princessmargaret.

About PTW

PTW is a world leader in high-precision dosimetry solutions. Founded in 1922, the company is a pioneer in medical radiation measurement. PTW owns one of the oldest and largest accredited calibration laboratories in the field of ionizing radiation and established THE DOSIMETRY SCHOOL to promote the exchange of knowledge in clinical dosimetry. PTW operates globally with nine international subsidiaries and more than 350 employees worldwide. For more information, visit: https://www.ptwdosimetry.com/en/.

Media Contact

Lisa Goetz

Schubert b2b

610-269-2100 x244

lgoetz@schubertb2b.com

Share article on social media or email:

LifeDNA and University of Hawai’i Collaborate on Studying Why Certain Populations Are Hit Harder


Based on genetics, certain individuals and populations may be impacted more severely. LifeDNA’s scientists are working tirelessly to add to the body of knowledge regarding the effect of these genetic variations.

LifeDNA, Inc., a pioneering personal genomics company, has initiated a coronavirus study aimed at understanding why certain individuals and racial/ethnic groups are more prone to the infection and may suffer a more severe course of COVID-19.

“COVID-19 has upended daily life for citizens around the globe,” said Cyril Moukarzel, CEO of LifeDNA, Inc. “Based on genetics, certain individuals and populations may be impacted more severely. LifeDNA’s scientists are working tirelessly to add to the body of knowledge regarding the effect of these genetic variations.”

Honolulu-based LifeDNA is collaborating with molecular epidemiologist Maarit Tiirikainen, Ph.D., Associate Professor at the University of Hawai’i at Mānoa. The study will initially focus on the multi-ethnic population of Hawai‘i and genetic variants of the ACE2 gene as they relate to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

“There have been major differences in the rates of SARS-CoV-2 infection and the severe disease between the different geographic regions since the beginning of the COVID-19 pandemic, even among young individuals,” Dr. Tiirikainen said. “Epidemiological studies—so-called Genome Wide Association Studies (GWAS)—indicate that populations carry different variants of the ACE2 gene. This variation in the gene coding for the ACE2 receptor may have an effect on the number of ACE2 receptors on the lung cells, as well as on how effectively the virus binds to the receptor. There may also be genetic differences in immune and other important genes explaining why some people get more sick than others.”

For more than three years now, LifeDNA has been utilizing published GWAS data to provide reports on the association of genetic variants to various human traits. In this global health crisis, LifeDNA will focus its scientific resources on determining why certain individuals and ethnic populations seem more prone to the SARS-CoV-2 infection and may also have a more severe course of the COVID-19 disease. The differences in the severity of the disease may also have an effect on future lung cancer incidences in different populations, especially when augmented by smoking.

The genotyping for the study will be done at the Kaka’ako Genomics and Bioinformatics Shared Resource (co-directed by Dr. Tiirikainen) at the University of Hawai‘i Cancer Center.

LifeDNA expects that the findings of its study will allow for identifying the most vulnerable individuals and populations ahead of time in future SARS virus-family outbreaks. The company also envisions pharmacogenomics collaborations on life-enhancing and lifesaving preventive therapeutics, such as those utilizing CRISPR-Cas9 gene editing technology. While LifeDNA has yet to initiate formal partnership dialogue, companies with this relevant domain expertise include CRISPR Therapeutics AG, Editas Medicine, Inc. and Intellia Therapeutics, Inc.

About LifeDNA

LifeDNA is a leading personal genomics company headquartered in Honolulu. The company’s mission is to help people lead healthier and more fulfilling lives by unlocking the power of their unique DNA. LifeDNA’s offerings include a self-administered, cheek swab DNA test kit and reports on 137 traits in the following categories: health, personality, fitness, nutrition and skin. Consumers who have already taken a DNA test with 23andMe, Ancestry or MyHeritage may upload their DNA raw data files (DNA test results) to gain deeper insight with LifeDNA’s critically acclaimed reports. LifeDNA is headquartered in Honolulu and privately backed by Markowitz Trust and other investors. Learn more at http://www.lifedna.com. Like LifeDNA on Facebook at https://www.facebook.com/golifedna/. Follow LifeDNA on Twitter @golifedna.

About the University of Hawai’i Cancer Center

The University of Hawai’i Cancer Center through its various activities, cancer trial patients and their guests, and other visitors adds more than $54 million to the O‘ahu economy. It is one of only 71 research institutions designated by the National Cancer Institute. Affiliated with the University of Hawaiʻi at Mānoa, the Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawai’i and the Pacific. Learn more at http://www.uhcancercenter.org. Like UC Cancer Center on Facebook at http://www.facebook.com/UHCancerCenter. Follow the UH Cancer Center on Twitter @UHCancerCenter.

Share article on social media or email:

Global Non-Profit Black Jaguar-White Tiger Foundation Launches Exclusive Line Of Hemp Products For Pets


Plant-Based Hemp Oil for Pets

For now, be sure to know that you are giving the absolute best Hemp on the Planet.”

Black Jaguar-White Tiger Foundation, the global non-profit is launching a line of true full-spectrum hemp products exclusively for pets. The new range, Black Jaguar-White Tiger Hemp consists of a chewable tablet and tincture available in a morning and night dosage.

This is the first human and animal product the foundation has launched.

“It is my great Honor, to finally introduce to you, what I consider to be the finest line of Hemp Products in the world; both for Animals and Humans. My Foundation has been Blessed to have been Loved and supported by millions of people around the world. They send us their Love, their Blessings, and when they can, their economic support,” said Founder Eduardo Serio.

In the coming days, Black Jaguar-White Tiger Foundation will start distributing the products from bjwthemp.com. Customers in North America will be able to provide the best dose of wellness for their pets.

Black Jaguar-White Tiger Hemp is the only whole plant-based hemp pet product on the market. Using American grown hemp, the tincture and tablets are made via a process that uses a low temperature and no harmful chemicals. In doing so, the healing power of the plant is kept intact and the product provides a true entourage healing effect. Other plant products are further blended to ensure pets receive the right dose of wellness at the right time. The product is then tested before packaging, in which customers can view the results from a QR code online.

The true full-spectrum pet tablets come in a bacon flavor and are available in an AM and PM chew. The AM chew provides a boost of energy throughout the day, while the PM chew, helps a pet settle down to promote deep sleep.

Much like the tablets, the tincture is available in an AM and PM version. In one fast-acting drop, a pet will receive a dose of energy during the day and a restorative sleep throughout the night. It can be given directly or added to food. The tincture is suitable for anxious and stressed pets and can help ease long car rides. It is made of a blend of cannabinoids, omega fatty acids, and vitamins—all vital for wellbeing.

“When Existence gave me the idea of using Hemp on some of our kids, I called Seth and Kamal and partnered with them. We put together what in our opinion will be the biggest game-changer in the Hemp industry. I can’t wait for you to try it. Many more products will be incorporated as time goes by. For now, be sure to know that you are giving the absolute best Hemp on the Planet.”

The pet tablets retail for $44.99 and the tincture retails for $39.99, which is available for purchase online only.

“I donated all of my future proceeds, which are close to 50% of the total, to my kids. The Black Jaguar-White Tiger Foundation owns the shares that initially belonged to me. In the end, all I do is for my kids, so better that they own it than me. It’s all for love,” said Serio.

Share article on social media or email:

Luminare Deploys Free COVID-19 Quickscreen™ via CheckForCorona.com


News Image

We saw an opportunity to serve people and help both first responders and the public health authorities during this crisis by reducing the pressure on the healthcare and testing systems.

Luminare, a Houston-based health technology and software company, has rallied to join the fight against COVID-19. Utilizing its patented platform developed for detecting sepsis, the company rapidly developed and deployed Quickscreen™, a web-based software platform, utilized to pre-screen for COVID-19 in at-risk populations. By partnering with community organizations to offer assistance and expertise, Luminare is focused on preventing further spread of the virus.

Offered free of charge for any individual or organization in need, CheckForCorona.com has been translated into eight different languages and screened more than 100,000 patients across every continent on the planet.

“We already had a very robust platform, Sagitta™, that is used by nurses and doctors for critically evaluating patients in hospitals for sepsis. By utilizing the platform to pre-screen for COVID-19, we saw an opportunity to serve people and help both first responders and the public health authorities during this crisis by reducing the pressure on the healthcare and testing systems,” said Sarma Velamuri, M.D., CEO of Luminare.

The goal of CheckForCorona.com is to help people self-assess, better understand their symptoms, and avoid unnecessary phone calls to already overwhelmed call centers. The website has already saved more than 50,000 superfluous phone calls to date. Additionally, Quickscreen provides communities and organizations a method of collecting valuable epidemiological data that can help shed light on the transmission and severity of coronavirus in specific locations.

Locally, the platform has been adopted by Harris County Public Health, the City of Houston, Fort Bend County, with pending agreements with additional counties, cities, and organizations in Texas.

“We have had a fantastic response to the solution in the face of limited availability of swab and blood tests,” said Dr. Velamuri. “Thousands of people who otherwise would have spent hours sitting in their car waiting for a test only to be turned away, or those experiencing long wait times on hold waiting for a call center nurse, are now instead able to know their appropriate action based on zip code in just 30 seconds. The epidemiological data we have collected is incredibly valuable, and we want to help state and national authorities get ahead of the curve by predicting disease hotspots weeks before testing will show where our efforts should be directed.

“Another advantage is the unique identifier per assessment result that is completely anonymous and can be used for tying incidence data to an individual test without the burden of scrubbing identifiable patient information for public reporting,” Dr. Velamuri concluded.

Luminare is also working with Houston’s Healthcare for the Homeless and is providing a web-based tool to allow frontline workers to triage homeless residents for quarantine, testing or other care.

Interested hospitals and community organizations needing a platform to assist with self-assessment and coronavirus screening should contact Luminare here.

About Luminare

Luminare’s, founded in 2014 in Houston, Texas, is on a mission to stop sepsis deaths and morbidity in hospitals through efficient, software-driven detection. Sagitta, the software platform focused on preventing sepsis, is named after arrow in Latin. Deployed in Texas and Arkansas hospitals, Sagitta has decreased sepsis mortality rates. Hospitals have reported that no patients have developed septic shock since deployment, in-patient code-blue events decreased by 27 percent, and emergent intubations and rapid response calls decreased by 11 percent. In Long Term Acute Care facilities, the rate of sepsis re-admissions went to zero.

Luminare has partnered with the Centers for Disease Control and Prevention on the interoperability showcase on sepsis to demonstrate the platform’s advantages to effectively move patient care. The company was awarded the Most Promising Web & IT company in the U.S. in 2017 by Jones School of Business at Rice University and is also an alum from cohort X6 of the Texas Medical Center’s accelerator, TMCX+ To learn more visit https://www.luminaremed.com.

Share article on social media or email:

Crutchfield Dermatology Offers Free Teledermatology Online Appointments for Those in Need


News Image

Charles E. Crutchfield III, M.D.

In these unprecedented times, we are fortunate to be able to help and feel honored to serve all those with dermatologic needs, including those who can’t afford it.” said Charles E. Crutchfield III, M.D., Medical Director of CrutchfieldDermatology.com

During a pandemic, other human health issues don’t disappear. In fact, if additional medical clinics close or have limited availability, patients suffering from many different medical ailments will be forced to take up valuable appointment spots in urgent care centers, emergency rooms, and even hospitals. That is why it is so essential to maintain a robust telemedicine capability to free up the burden and stress that could potentially burden those other healthcare facilities so they can focus on providing care for those who urgently need it.

At Crutchfield Dermatology, they have conducted hundreds of telemedicine (teledermatology) visits and are very comfortable seeing patients with virtual online visits. As a result, they have taken a national leadership position in telemedicine.

The schedulers at Crutchfield report excellent results as patients are happy to sign up for virtual online teledermatology visits. Patients love the ability to get their skincare needs addressed without having to go to urgent care. They can do so from the comfort, safety, and convenience of their own home. “Patients give the teledermatology visits very high ratings.” Commented Ashely N., lead nursing staff member.

Minnesota Governor Walz recently wrote a letter jointly with the Commissioners of Health and Commerce, urging health plans in Minnesota to extend coverage for most Minnesotans to receive medical care remotely – known as “telemedicine.” Other state leaders praised the effort as consistent with legislation aimed at expanding remote care. “Crutchfield Dermatology was ahead of the curve on this one and are seeing patients who need it, without charge,” commented Tim Quesnell, Clinic General Manager.

When it comes to online virtual telemedicine visits, Crutchfield Dermatology is incredibly flexible. They utilize several telemedicine platforms including, but not limited to, Zoom, Skype, FaceTime, Google Duo, WhatsApp, GoToMeeting, Slack cell phones, and even emailed photos combined with landlines. As a result, Crutchfield Dermatology can now serve about 95% of all patients who need an online virtual dermatology appointment.

Another positive is that most skin conditions are very amenable to telemedicine. Dr. Crutchfield can see the problem right on the monitor. With the quality of most computer cameras and cell phones, the picture quality is outstanding. For the few visits where there is a suspicious lesion, the doctor can have the patients come into the clinic, with full safety precautions. In urgent cases, the clinic can handle acute medical needs, in-person, also. “In fact, we have detected several melanomas via teledermatology over the past few weeks,” reports Dr. Crutchfield.

“In these unprecedented times, we are fortunate to be able to help and feel honored to serve all those with dermatologic needs, including those who can’t afford it.” said Charles E. Crutchfield III, M.D., Medical Director of CrutcheldDermatology.com

All they have to do is call our telemedicine coordinator, Kelly M., at 651 209 3628, and she will take it from there.

About Charles E. Crutchfield III, M.D.:

Charles E. Crutchfield III, M.D., is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School. He is currently the Medical Director of Crutchfield Dermatology in Eagan and is a Benedict Distinguished Professor of Biology at Carleton College. Dr. Crutchfield has won numerous teaching and professional awards and is the co-author of a children’s book on sun protection a dermatology textbook and hundreds of medical articles. He is a member of the AΩA National Medical Honor Society, an expert consultant for WebMD and CNN, and a recipient of the Karis Humanitarian Award from the Mayo Clinic School of Medicine. Dr. Crutchfield has over 25 years of clinical experience serving patients.

Share article on social media or email: